Investor Presentaiton
13
Investor presentation
Full year 2022
Financial results - Full year of 2022
Novo NordiskⓇ
Change
Change
Full year 2022
In DKK million
Sales
Gross profit
Gross margin
Sales and distribution costs
Percentage of sales
Research and development costs
Percentage of sales
Administration costs
176,954
148,506
83.9%
(46,217)
26.1%
(24,047)
13.6%
(4,467)
Full year 2021
140,800
(reported)
(CER)
26%
16%
117,142
27%
17%
83.2%
(37,008)
25%
16%
26.3%
(17,772)
35%
29%
12.6%
(4,050)
10%
6%
Percentage of sales
2.5%
2.9%
Other operating income and expenses
1,034
332
211%
178%
Operating profit
74,809
58,644
28%
15%
Operating margin
42.3%
41.7%
Financial items (net)
Profit before income tax
(5,747)
69,062
436
59,080
17%
Income taxes
(13,537)
(11,323)
20%
Effective tax rate
19.6%
19.2%
Net profit
55,525
47,757
16%
Diluted earnings per share (DKK)
24.44
20.74
18%
CER: Constant exchange ratesView entire presentation